Xcout Intel
Maxwell Biosciences, Inc.
Maxwell Biosciences, Inc. is a biotechnology company based in Austin, Texas. It develops biomimetic, peptide-inspired anti-infective drugs designed to act as a synthetic immune system.
Subscribe to see Maxwell Biosciences, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Maxwell Biosciences, Inc. at a glance
Maxwell Biosciences, Inc. is a biotechnology company headquartered in United States. It has raised at least $66.7M across the 4 funding rounds on record. Its most recent funding round, Seed, raised $10.8M in March 2026. Xcout tracks 12 named people at Maxwell Biosciences, Inc., including Praveen Reddy (President, International Operations).
Maxwell Biosciences, Inc. leadership
- Praveen ReddyPresident, International Operations
- Jon McClureChief Technology Officer
- Lucas WentheChief Legal Officer
- Scotch McClureFounder, CEO & Chairman
- Sheetal ValiSenior Vice President, Head of R&D
- Meagan StoneSenior Director of Operations
6 more named people on record for Maxwell Biosciences, Inc., with roles, board committees and tenure — see the full roster →
Maxwell Biosciences, Inc. funding rounds
At least $66.7M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $10.8M | 5 named | |
| Seed | $20M | 5 named | |
| SEC Form D filing | $25M | — | |
| SEC Form D filing | $10.9M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Maxwell Biosciences, Inc. competitors
A few of Maxwell Biosciences, Inc.'s closest competitors — see the full list of competitors and alternatives →
Maxion Therapeutics is a biotechnology company headquartered in Cambridge, England, utilizing proprietary KnotBody technology to discover and develop first-in-class protein therapeutics.
Avicenna Biosciences, Inc. is a biotechnology company that uses machine learning-enhanced medicinal chemistry to accelerate drug discovery and optimization.
Aeolus Pharmaceuticals, Inc. is a biopharmaceutical company located in Mission Viejo, California, focused on developing a platform of compounds for biodefense and fibrosis applications.
NeuroX1 Inc. is a for-profit biotechnology startup founded in 2021 with headquarters in Austin, Texas, operating a target identification and drug discovery platform that utilizes proprietary technology.
Launched in 2022 and headquartered in Seattle, Washington, Vilya is an AI peptide company co-founded by scientists from the Institute of Protein Design. The company uses artificial intelligence and synthetic biology to design novel macrocycle therapeutics inspired by nature.
General Biotechnologies develops programmable synthetic biology platforms that use edible microbes to manufacture and deliver peptide therapeutics. The company primarily serves the pharmaceutical industry by reformulating discontinued peptide drugs into low-cost, needle-free oral medications and providing field-deployable biomanufacturing kits.
Get Maxwell Biosciences, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Maxwell Biosciences, Inc. in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- 4 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access